0001899924-21-000001.txt : 20211216 0001899924-21-000001.hdr.sgml : 20211216 20211216145902 ACCESSION NUMBER: 0001899924-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211216 DATE AS OF CHANGE: 20211216 EFFECTIVENESS DATE: 20211216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIN-30 Neurexis Therapeutics, LLC CENTRAL INDEX KEY: 0001899924 IRS NUMBER: 873578108 STATE OF INCORPORATION: AR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-425358 FILM NUMBER: 211497526 BUSINESS ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 BUSINESS PHONE: 4795712592 MAIL ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 D 1 primary_doc.xml X0708 D LIVE 0001899924 VIN-30 Neurexis Therapeutics, LLC 535 W. RESEARCH CENTER BLVD. SUITE 135 FAYETTEVILLE AR ARKANSAS 72701 4795712592 ARKANSAS None None Limited Liability Company true 2021 Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Director CEO of Manager. Other Decline to Disclose 06b false 2021-12-10 false true false 5000 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS NC NORTH CAROLINA TX TEXAS false 500000 45000 455000 false 5 0 0 0 false VIN-30 Neurexis Therapeutics, LLC Robert Calvin Goforth Robert Calvin Goforth CEO of Manager 2021-12-16